In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.

The novel imidazoisoquinoline SDZ 62-434, originally identified as a platelet-activating factor (PAF) antagonist, has antiproliferative activity in a range of cell lines from human solid and haematological malignancies. Using an MTT cytotoxicity assay, IC50 values of 5 microM - 111 microM were obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunton, V. G., Workman, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968438/
https://www.ncbi.nlm.nih.gov/pubmed/8388233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968438/
https://www.ncbi.nlm.nih.gov/pubmed/8388233

Ejemplares similares